We read with concern the recent article by Zormpas et al., 'Eligibility for subcutaneous implantable cardioverterdefibrillator in adults with congenital heart disease'. 1 The authors reported a high (83%) rate of eligibility for subcutaneous implantable cardioverter-defibrillator (S-ICD) in the adult congenital heart disease (ACHD) population, which is in sharp contrast to several previous ACHD studies: by Wang et al. 2 (60% eligibility), by Alonso et al. 3 in mixed ACHD (75% eligibility) and tetralogy of Fallot (77% eligibility), 4 and by Garside et al. 5 (75% eligibility; left-sided only).One discrepancy is between the reported data in figures and what is discussed in the results section. Figure 1 in the manuscript 1 shows that 22% of patients failed the left-sided automated screening test and 25% of patients failed the right-sided automated test. The authors stated that only 'two patients were found eligible in the left parasternal but not in the right parasternal position, while all patients found eligible in the right parasternal position were also eligible in the left parasternal position'. Mathematically, it is not possible to achieve the reported 83% rate of eligibility per written findings, but, instead, figure 1 provides results more consistent with previous studies. [2][3][4] The authors 1 did not discuss possible reasons for disagreement of their findings with previous studies. It is essential to discuss the limitations of the study in order for the reader to gain perspective of the study.The methods included the use of an automated Boston-Scientific screening test. However, details about the Boston-Scientific programmer settings of the test and whether or not SMART Pass S-ICD function (ECG filtering settings) 6 was considered were not included. Furthermore, it is unusual for the automated screening test to yield 'no results.' Further details of the automated test with 'no results' would be helpful for troubleshooting and meaningful interpretation. It would be necessary if the authors compared their results with a previous comprehensive evaluation of the automatic screening tool. 7 An important limitation of the study was that a single investigator performed the ECG-based screening test, and therefore, inter-rater and intra-rater agreement has not been investigated. There was also no mention of investigator